J&J adds Chile, Argentina and Peru to Latin America COVID-19 vaccine trials

U.S. pharmaceutical company Johnson & Johnson has added Chile, Argentina and Peru to the Latin nations where it plans to conduct Phase III trials for its vaccine against COVID-19. The study will involve 60,000 volunteers from Brazil, Chile, Colombia, Peru, Argentina and Mexico and will be coordinated by J&J’s pharmaceutical unit Janssen and local academic centers.

Source: Devdiscourse